This case study explores a 37-year-old Moroccan female who developed brief psychotic disorder following a severe COVID-19 infection and significant stressors, including the sudden death of her father. She presented with paranoia, delusions, and agitation, which improved with risperidone and lorazepam. This case underscores the need for vigilant psychiatric assessment and timely intervention in post-COVID-19 psychosis.
No takes yet. Share an insight, caveat, or question.
SARA et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: